The law firm behind Shine Lawyers swung back to profit and lifted half-year EBITDA 77% as its personal injury engine fired. With a trailing yield near 8.4% and full-year numbers due on 28 August, is a re-rating brewing—or is the market still wary?

The central question

Few small-cap turnaround stories on the ASX carry as much history as Shine Justice Ltd (ASX: SHJ). The company that operates Shine Lawyers—one of Australia's best-known personal injury and class action firms—has spent years rebuilding investor trust after accounting controversies last decade. Its half-year to 31 December 2025 delivered a genuine profit recovery and a sharp jump in earnings. The question for investors is whether that momentum, paired with a headline dividend yield above 8%, marks the start of a durable re-rating, or whether structural risks keep the shares anchored below 60 cents.

What Shine Justice does

Shine Justice, formerly Shine Corporate Ltd, listed on the ASX in 2013 and rebranded to reflect its consumer-litigation focus. Its core business is contingency-based legal services: it runs personal injury claims (motor accident, medical negligence, workers' compensation and public liability) largely on a "no win, no fee" basis, meaning revenue is recognised as cases progress but cash is often collected only on settlement. A second arm runs class actions, some funded by third parties and some self-funded, which are lumpier and can tie up working capital for years. This model produces high accounting profits but a persistent gap between reported earnings and cash—a nuance that has tripped up investors before and remains central to reading the accounts.

The latest catalyst

Dividend analysis

Shine declared a fully franked interim dividend of 1.5 cents per share for the half, in line with its interim payment across the prior four years, with an ex-date of 7 April 2026 and payment on 24 April 2026. Combined with the fully franked 3.5-cent final dividend from FY25 (ex-date 29 September 2025), the trailing 12-month distribution is 5.0 cents per share, fully franked.

On the most recent share prices I could verify—approximately $0.59 on 7 July 2026 and $0.60 on 13 July 2026—that 5.0-cent trailing payout equates to an indicative trailing yield of roughly 8.3% to 8.5%. The widely quoted 8.4% figure sits squarely in that band and is a fair characterisation, though it is a trailing, indicative number, not a forward promise. Because the dividends are fully franked, the grossed-up yield to a fully-taxed Australian investor is materially higher, in the order of 11–12%. Two cautions: the reported payout ratio is around 82%, leaving limited headroom; and, given the cash-timing dynamics above, dividend cover from actual cash rather than accounting profit is thinner than the headline suggests. Past dividends are not a guarantee of future payments.

Strategic outlook and the bull case

The bullish reading is straightforward. Personal injury—the more predictable, higher-volume engine—is scaling, margins are expanding, and management describes accelerating case momentum. If that continues into the full-year result on 28 August, and if delayed class action receipts convert to cash, the market may reward both improving profitability and a high, franked income stream. At a market capitalisation near $100 million on roughly 168 million shares, a modest earnings re-rating from a low base could move the shares meaningfully. For income-oriented investors, a fully franked yield above 8% is a scarce commodity.

The risks

Against that, the risks are equally clear and should not be minimised. Shine's earnings quality depends on judgement-heavy estimates of work-in-progress and case recoveries—the same category of assumption that has caused problems before, and which produced this half's $2.3 million write-down. Cash conversion lags profit, and net debt of $79.9 million must be serviced regardless of settlement timing. Class action outcomes are inherently binary and can swing results. Regulatory change to no-win-no-fee or litigation funding rules is an ever-present overhang. And with an ~82% payout ratio, any earnings stumble could pressure the dividend.

Balanced conclusion

Shine Justice has produced a credible profit turnaround, and the 77% half-year EBITDA jump, the return to profit and the ~8.4% trailing yield all check out as reported facts for the December 2025 half. Whether that translates into a sustained "breakout" hinges on the 28 August full-year result and, above all, on converting accounting profit into cash. The upside case rests on momentum and a rich franked yield; the caution rests on earnings quality, gearing and a stretched payout. This is analysis and context, not advice—readers should weigh both sides and their own circumstances. Past performance and past dividends do not guarantee future results.